IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer. Swiss Medical Weekly, [S. l.], v. 145, n. 5152, p. w14215, 2015. DOI: 10.4414/smw.2015.14215. Disponível em: https://www.smw.ch/index.php/smw/article/view/2122. Acesso em: 13 oct. 2025.